— Know what they know.
Not Investment Advice
Also trades as: IMC.AX (ASX) · $vol 0M

IMRN NASDAQ

Immuron Limited
1W: -6.0% 1M: -6.8% 3M: -2.7% YTD: +37.1% 1Y: -42.9% 3Y: -43.5% 5Y: -77.5%
$1.09
-0.04 (-3.54%)
 
Weekly Expected Move ±33.7%
$0 $1 $1 $1 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 52 · $7.0M mcap · 7M float · 23.97% daily turnover · Short 30% of daily vol

📊 Key Metrics

TTM
$13M
Revenue
+28.7% YoY
$-8M
Net Income
+27.8% YoY
$-6M
Free Cash Flow
+35.0% YoY
65.8%
Gross Margin
-68.8%
Op. Margin
-54.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-74.6%
ROA-63.3%
ROIC-356.5%

Valuation

P/E-3.1
P/B1.2
EV/EBITDA0.0

Leverage

Debt/Equity0.00
Current Ratio7.17
Interest Cov.-537.5x

Quality Scores

Piotroski F5/9
Altman Z—
Beneish M-3.34

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms